Home
About Us
Products
Manus Aktteva Biopharma LLP, an ISO 9001: 2008 certified sourcing & export concern takes pride in fulfilling your requirements of Nutraceuticals, Specialty Chemicals, Pharmaceutical APIs and their advance level intermediates from ISO Certified, GMP, CGMP & USFDA approved units with supportive regulatory documentations like DMF, EDMF, COS, USDMF etc. We wish to state that anyone interested in sourcing any special molecules, APIs, Intermediates, Chiral Compounds etc. and feels it is difficult for early completion of tasks, please call on us and TEST US TO GET THE BEST OF US.
Category
Recommended
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk. Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
Enquiry
Quick Links
Blog
Contact Us

Moxifloxacin hydrochloride (CAS No.: 186826-86-8)

Manus Aktteva Biopharma LLP is an ISO 9001:2015 Certified Global Supplier based in India for the product Moxifloxacin hydrochloride, 186826-86-8.
We offer the product Moxifloxacin hydrochloride, 186826-86-8 from our manufacturer / supplier / principals for your Research and Development / Evaluation or Commercial requirements, based on the product's availability from our network. We can also offer Moxifloxacin hydrochloride, 186826-86-8 intermediates with the supportive technical package required for evaluation.
We respect our customer's requirements of strict regulatory compliance and specification needs by offering the API - Active Pharmaceutical Ingredients and intermediates transparently while offering easy access to manufacturer / supplier / principals with affordable and high-quality raw materials.
If you are looking for the API -Active Pharmaceutical Ingredients Moxifloxacin hydrochloride, 186826-86-8 manufacturer supplier who is reliable and meets your required quality standard requirements in the first place, you are at the right place!

CAS number:

186826-86-8

Chemical Name:

Moxifloxacin hydrochloride,(1'S,6'S)-1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride, Moxifloxacin hydrochloride (CAS No.: 186826-86-8)

Pharmacopeia:

USP, EP, BP, In House

Manufacturer Certificate:

GMP, GMP - SFDA, cGMP, EUGMP, WHO GMP, ISO Certified, USFDA, Cofepris Mexico

Application:

For R&D Purpose

Properties
Related Intermediates

Synonym

Moxifloxacin hydrochloride,(1'S,6'S)-1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride, Moxifloxacin hydrochloride (CAS No.: 186826-86-8)

Molecular Formula

C21H24FN3O4.HCl

Molecular Weight

437.90

Manufacturer Specifications

Available on request

Packing

Export worthy packing

Material Safety Data Sheet

Available on request

Comments

REGULATORY APPROVALS : EU Compliant

Product Name	CAS No.
Quinolinic acid	89-00-9	View \| Inquire
2,3-Pyridinedicarboxylic anhydride	699-98-9	View \| Inquire
(S,S)-2,8-Diazabicyclo[4,3,0]nonane	151213-42-2/151213-40-0	View \| Inquire
(S,S)-2,8-Diazabicyclo[4.3.0]nonane	151213-40-0	View \| Inquire

Description:

Moxifloxacin is a fourth-generation synthetic fluoroquinolone antibacterial agent developed by Bayer AG (initially called BAY 12-8039).Moxifloxacin is used to treat a number of infections, including: respiratory tract infections, cellulitis, anthrax, intraabdominal infections, endocarditis, meningitis, and tuberculosis

Manufacturer Documentation / Approvals :

USDMF	EDMF	CEP / COS	TGA - AUSTRALIA	DMF (OPEN PART)	DMF (CLOSED PART)	DMF - CTD

Products protected by valid patents from a manufacturer are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use from a manufacturer in accordance with 35 USC 271 +A13(1)
Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Manus Aktteva Biopharma LLP assumes no responsibility/liability in case of being imparted with goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual manufacturer. Manus Aktteva makes no representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual property which includes patents of a manufacturer in its products or services for any purpose.
Manus Aktteva Biopharma LLP warns the sellers not to sell any goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual or a manufacturer.
Manus Aktteva Biopharma LLP warns the buyers not to use/procure any goods from a manufacturer to achieve a product which might be knowingly causing an infringement of intellectual property in any manner whatsoever which includes patent rights of any individual manufacturer.
This website is updated and maintained by Manus Aktteva Biopharma LLP. As a matter of policy, Manus Aktteva Biopharma LLP does not entertain any anonymous or pseudonymous inquiries.

Are you looking for Moxifloxacin hydrochloride (CAS No.: 186826-86-8) with documentation like PMDA - JAPAN, DMF - CANADA, MHRA - UK, DMF - KOREA, AIFA - ITALY, TDP, MEDSAFE - NEW ZEALAND, HEALTH CANADA, JDMF, JAPAN - AFM, DCGI, ICH, COPP, TDMF, Written Confirmation? Please click here to send us sourcing request.

Why Us